mediated cytolysis by downregulating cell surface expression of CD155 (nectin-like
molecule 5; poliovirus receptor), a ligand for the activating receptor DNAM-1 (CD226).
However, DNAM-1 is also recognized to bind a second ligand, CD112 (nectin-2). We now
show that HCMV targets CD112 for proteasome-mediated degradation by 48 h post-
infection, thus removing both activating ligands for DNAM-1 from the cell surface during …